ArticleAJPM focus2026
Colorectal Cancer Screening Compliance Among Sexual Minority Subpopulations After the 2021 Updated U.S. Preventive Services Task Force Guidelines: A Cross-Sectional Analysis.
Article in AJPM focus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The U.S. Preventive Services Task Force updated its colorectal cancer screening guidelines in 2021; however, little is known about adherence to these updated guidelines among sexual minority populations. Methods: Using data from the 2022 Behavioral Risk Factor Surveillance System, this study analyzed the adjusted prevalence ratios of up-to-date colorectal cancer screening across sexual orientation groups (straight, gay/lesbian, bisexual, and another sexual orientation [defined as something else]) using modified Poisson regression with robust variance estimation adjusted for sociodemographic factors. Analyses were further stratified by age group (45-49, 50-64, and 65-75 years) and sex. Results: The study included 173,381 respondents (weighted N=93,061,050) aged 45-75 years. Overall, the prevalence of up-to-date colorectal cancer screening ranged from 58.4% (another sexual orientation), 62.7% (bisexual), and 68.8% (straight) to 69.0% among gay/lesbian individuals ( Conclusions: Colorectal cancer screening among individuals with another sexual orientation consistently had a lower prevalence of up-to-date colorectal cancer screening than among straight and gay/lesbian individuals and did not differ significantly from that for gay/lesbian or bisexual individuals. This disparity was primarily driven by females and those aged 65-75 years, highlighting the need for age- and sex-tailored interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.